It has been reported that while oncogenic receptor tyrosine kinase (RTK) signaling induces SOX2 expression during transformation in engineered glioblastoma mouse models, the maintenance of SOX2 expression and its tumor-driving transcriptional network appears independent of ongoing aberrant RTK activity12. The gene discussed is SOX2; the disease is neoplasm.